Skip to main content
Year archive

Medivir — 2021 filings

All 52 regulatory filings released by Medivir (MVIR) in 2021, sourced directly from the official regulator.

52 Filings
2021 Period
2021 filings (52)
Filing Released Lang
Major Shareholding Notification 2021
Major Shareholding Notification
2021-12-20 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-12-17 English
Director's Dealing 2021
Director's Dealing
2021-12-01 English
Klinisk studie med birinapant inledd av IGM Biosciences
Regulatory Filings
2021-11-04 Swedish
Birinapant clinical study initiated by IGM Biosciences
Regulatory Filings
2021-11-04 English
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-11-03 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-11-03 English
Medivir utser Jens Lindberg till verkställande direktör
Board/Management Information
2021-10-25 Swedish
Medivir Appoints Jens Lindberg as Chief Executive Officer
Board/Management Information
2021-10-25 English
Medivir bjuder in till telefonkonferens om nya kliniska data och fortsatta studier med MIV-818
Regulatory Filings
2021-09-16 Swedish
Medivir invites to a conference call on new clinical data and further studies with MIV-818
Regulatory Filings
2021-09-16 English
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-08-19 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-08-19 English
Medivir stärker affärsutvecklingspotentialen för remetinostat genom omförhandlat flerpartsavtal
Regulatory Filings
2021-08-16 Swedish
Medivir strengthens the business development potential of remetinostat through renegotiated multi-party agreement
Regulatory Filings
2021-08-16 English
Resolutions at the Annual General Meeting in Medivir on 5 May 2021
AGM Information
2021-05-05 English
Beslut vid årsstämma i Medivir den 5 maj 2021
AGM Information
2021-05-05 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-04-28 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-04-28 English
Annual Report 2020
Annual Report FY 2020
2021-04-06 Swedish
Annual Report 2020
Annual Report FY 2020
2021-04-06 English
Antalet aktier och röster i Medivir
Share Issue/Capital Change
2021-03-31 Swedish
Number of shares and votes in Medivir
Share Issue/Capital Change
2021-03-31 English
Kallelse till årsstämma i Medivir AB (publ)
AGM Information
2021-03-29 Swedish
Notice of Annual General Meeting of Medivir AB (publ)
AGM Information
2021-03-29 English
Förändringar i Medivirs ledning och styrelse
Board/Management Information
2021-03-22 Swedish
Changes in Medivir’s management and Board of Directors
Board/Management Information
2021-03-22 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-03-18 English
Resolution at the extraordinary general meeting in Medivir on 11 March 2021
Share Issue/Capital Change
2021-03-11 English
Beslut vid extra bolagsstämma i Medivir den 11 mars 2021
Share Issue/Capital Change
2021-03-11 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report FY 2020
2021-02-26 Swedish
Audit Report / Information 2020
Audit Report / Information FY 2020
2021-02-26 English
Antalet aktier och röster i Medivir
Share Issue/Capital Change
2021-02-26 Swedish
Number of shares and votes in Medivir
Share Issue/Capital Change
2021-02-26 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-02-19 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-02-17 English
MEDIVIR ANNOUNCES FINAL OUTCOME OF THE OVERSUBSCRIBED RIGHTS ISSUE AND RESOLVES ON OVER-ALLOTMENT
Capital/Financing Update
2021-02-09 English
MEDIVIR OFFENTLIGGÖR SLUTLIGT UTFALL I ÖVERTECKNAD FÖRETRÄDESEMISSION OCH BESLUTAR OM ÖVERTILLDELNING
Capital/Financing Update
2021-02-09 Swedish
Kallelse till extra bolagsstämma i Medivir AB (publ)
AGM Information
2021-02-08 Swedish
Notice of extraordinary general meeting of Medivir AB (publ)
AGM Information
2021-02-08 English
MEDIVIR PROPOSES DIRECTED ISSUE OF APPROXIMATELY SEK 28 MILLION TO THE COMPANY’S EXISTING SPECIALIST INVESTOR LINC
Capital/Financing Update
2021-02-07 English
MEDIVIR FÖRESLÅR RIKTAD NYEMISSION OM CIRKA 28 MSEK TILL BOLAGETS BEFINTLIGA SPECIALISTINVESTERARE LINC
Capital/Financing Update
2021-02-07 Swedish
PRELIMINARY OUTCOME IN MEDIVIR’S RIGHTS ISSUE – OVERSUBSCRIBED BY 93.5 PER CENT
Capital/Financing Update
2021-02-05 English
PRELIMINÄRT UTFALL I MEDIVIRS FÖRETRÄDESEMISSION – ÖVERTECKNAD MED 93,5 PROCENT
Capital/Financing Update
2021-02-05 Swedish
Major Shareholding Notification 2021
Major Shareholding Notification
2021-01-21 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-01-18 English
Medivir publishes prospectus relating to the rights issue – including new financial information
Capital/Financing Update
2021-01-18 English
Medivir offentliggör prospekt avseende företrädesemissionen – inkluderande ny finansiell information
Capital/Financing Update
2021-01-18 Swedish
Beslut vid extra bolagsstämma i Medivir den 13 januari 2021
AGM Information
2021-01-13 Swedish
Resolutions at the extraordinary general meeting in Medivir on 13 January 2021
AGM Information
2021-01-13 English
Medivir tecknar exklusivt licensavtal med IGM Biosciences för birinapant
Regulatory Filings
2021-01-11 Swedish
Medivir enters into exclusive licensing agreement with IGM Biosciences for birinapant
Capital/Financing Update
2021-01-11 English